Vinge has advised CELLINK AB (publ) in connection with the acquisition of all shares in Ginolis Oy. Ginolis conducts operations in relation to automated diagnostics and provides advanced robotic solutions to the medical- and diagnostics industries.
The purchase price on a cash and debt free basis amount to EUR 70 million. Forty per cent of the purchase price will be paid with newly issued class B shares in CELLINK, with the remainder in cash.
Vinge’s team mainly consisted of Anders Strid, Johanna Hamrefält (project manager M&A), Anna Maria Lagerqvist Gahm and Alexander Lindeberg (IP), Aleksandar Bajic (M&A), Martin Svanberg (W&I) in addition to Edin Agic (Capital Markets). Krogerus Attorneys acted as local counsel in Finland.
